British opiod drugmaker Indivior is facing lawsuits from 35 U.S. states alleging it employed a product hopping strategy to keep generic versions of Suboxone off the market. (Source: PharmaManufacturing.com)
Oxycontin Treatment Directory Doctors : Centers : Detox : Info
British opiod drugmaker Indivior is facing lawsuits from 35 U.S. states alleging it employed a product hopping strategy to keep generic versions of Suboxone off the market. (Source: PharmaManufacturing.com)